Biotechnology - Cambridge, Massachusetts, United States
General Biotechnologies identifies and develops undervalued discoveries in the life sciences. Our flagship program — Nivien Therapeutics — is a venture-backed oncology platform.Contact: Nathaniel Brooks Horwitz, Founder (nathaniel@generalbiotechnologies.com)
Gmail
Google Apps